AMI KETLEY ami.ketley@nottingham.ac.uk
Research Fellow
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines
Ketley, Ami; Chen, Catherine Z.; Li, Xin; Arya, Sukrat; Robinson, Thelma E.; Granados-Riveron, Javier T.; Udosen, Inyang; Morris, Glenn E.; Holt, Ian; Furling, Dennis; Chaouch, Soraya; Haworth, Ben; Southall, Noel; Shinn, Paul; Zheng, Wei; Austin, Christopher P.; Hayes, Christopher J.; Brook, J. David
Authors
Catherine Z. Chen
Xin Li
Sukrat Arya
Thelma E. Robinson
Javier T. Granados-Riveron
Inyang Udosen
Glenn E. Morris
Ian Holt
Dennis Furling
Soraya Chaouch
Ben Haworth
Noel Southall
Paul Shinn
Wei Zheng
Christopher P. Austin
CHRIS HAYES chris.hayes@nottingham.ac.uk
Professor of Organic Chemistry
DAVID BROOK david.brook@nottingham.ac.uk
Professor of Human Genetics
Abstract
Myotonic dystrophy (DM) is a multi-system neuromuscular disorder for which there is no treatment. We have developed a medium throughput phenotypic assay, based on the identification of nuclear foci in DM patient cell lines using in situ hybridization and high-content imaging to screen for potentially useful therapeutic compounds. A series of further assays based on molecular features of DM have also been employed. Two compounds that reduce and/or remove nuclear foci have been identified, Ro 31-8220 and chromomycin A3. Ro 31-8220 is a PKC inhibitor, previously shown to affect the hyperphosphorylation of CELF1 and ameliorate the cardiac phenotype in a DM1 mouse model. We show that the same compound eliminates nuclear foci, reduces MBNL1 protein in the nucleus, affects ATP2A1 alternative splicing and reduces steady-state levels of CELF1 protein. We demonstrate that this effect is independent of PKC activity and conclude that this compound may be acting on alternative kinase targets within DM pathophysiology. Understanding the activity profile for this compound is key for the development of targeted therapeutics in the treatment of DM.
Citation
Ketley, A., Chen, C. Z., Li, X., Arya, S., Robinson, T. E., Granados-Riveron, J. T., …Brook, J. D. (2014). High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Human Molecular Genetics, 23(6), https://doi.org/10.1093/hmg/ddt542
Journal Article Type | Article |
---|---|
Publication Date | Mar 6, 2014 |
Deposit Date | Apr 15, 2014 |
Publicly Available Date | Apr 15, 2014 |
Journal | Human Molecular Genetics |
Print ISSN | 0964-6906 |
Electronic ISSN | 1460-2083 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 23 |
Issue | 6 |
DOI | https://doi.org/10.1093/hmg/ddt542 |
Public URL | https://nottingham-repository.worktribe.com/output/725602 |
Publisher URL | http://hmg.oxfordjournals.org/content/23/6/1551 |
Files
Hum._Mol._Genet.-2014-Ketley-1551-62.pdf
(1.2 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
A mild synthesis of substituted 1,8-naphthyridines
(2019)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search